Related to Fig 2. CD24-Fc treatment reduces HIV-1 pathogenesis during cART.

<p>Humanized mice were infected and treated as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1012826#ppat.1012826.g001" target="_blank">Fig 1A</a> and splenocytes were analyzed by FACS on termination. (A) Representative FACS plot...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autor principal:	Guangming Li (607051) (author)
Altres autors:	Jianping Ma (816945) (author), Haisheng Yu (607054) (author), Ourania Tsahouridis (11909960) (author), Yaoxian Lou (22022137) (author), Xiuting He (11909963) (author), Masaya Funaki (11909966) (author), Pan Zheng (25267) (author), Yang Liu (4829) (author), Lishan Su (33524) (author)
Publicat:	2025
Matèries:	Medicine Microbiology Cell Biology Neuroscience Physiology Biotechnology Immunology Cancer Mental Health Infectious Diseases Virology Chemical Sciences not elsewhere classified promising new therapeutic suboptimal immune reconstitution cd8 central memory fc may provide div >< p reduced immune hyper treating chronic inflammation pwh ), leading fc resolves inflammation associated molecular patterns 1 viral rebound systemic immune activation cart </ p chronic inflammation immune hyperactivation reduced hiv hiv cd8 chronic hiv suppressive cart retroviral therapy people infected inflammatory properties increased risk improved control humanized mice fusion protein findings indicate cell activity associated diseases aids events 1 reservoirs 1 infection
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Related to Fig 2. CD24-Fc treatment reduces HIV-1 pathogenesis during cART.

Ítems similars